Tag: PRMT5 inhibitor program
Victorian research centre inks major pharma deal
The Australian Cancer Therapeutics Cooperative Research Centre (CTx), their UK based research and commercialisation partner Cancer Research Technology (CRT) and global pharmaceutical giant MSD...
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
